Exhibit 99.1 Innate Pharma Reports Full Year 2022(1) Financial Results and Business Update MARSEILLE, France--(BUSINESS WIRE)--March 23, 2023--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its consolidated financial results1 for the year ending December 31, 2022. The consolidated financial statements are attached to this press release. "In 2022 we made important progress in our pipeline, both on our clinical and preclinical projects as well as maintaining a ...